Long Non‑coding RNA LINC00238 Suppresses the Malignant Phenotype of Liver Cancer by Sponging MiR‑522

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2022 Jan 11

PMID 35014686

Authors

Hong-Gang Qian

Qiong Wu

Jian-Hui Wu

Xiu-Yun Tian

Wei Xu

Chun-Yi Hao

Affiliations

Soon will be listed here.

Abstract

Long non‑coding RNAs can regulate the malignant tumor phenotype either as tumor suppressors or oncogenes. The present study investigated the underlying mechanism of LINC00238 in liver cancer. LINC00238 was identified as a downregulated molecule in The Cancer Genome Atlas liver hepatocellular carcinoma dataset through Gene Expression Profiling Interactive Analysis software. Through gain‑ and loss‑of‑function experiments, LINC00238 was confirmed as a tumor suppressor that could not only decrease cell viability, migration and invasion , but also tumorigenesis and tumor metastasis . By cytoplasmic and nuclear RNA isolation, LINC00238 was confirmed to be predominantly cytoplasmic. Mechanistically, RNA pull‑down assays showed that LINC00238 sponged microRNA (miR)‑522 and then reversed the inhibitory effects on two downstream targets, secreted frizzled related protein 2 and dickkopf1. Collectively, LINC00238 was identified as a tumor suppressor that acts via sponging miR‑522 followed by silencing of downstream targets, suggesting that LINC00238 may have a key role in suppressing the malignant phenotype of liver cancer cells.

Citing Articles

Divergent transcriptomic profiles in depressed individuals with hyper- and hypophagia implicating inflammatory status.

Dan S, Hall J, Holsen L, Klengel T J Psychiatr Res. 2024; 179:209-219.

PMID: 39316935 PMC: 11532000. DOI: 10.1016/j.jpsychires.2024.09.020.

LncRNA RP11-93B14.5 promotes gastric cancer cell growth through PI3K/AKT signaling pathway.

Li Q, Zhu Z, Zhang H, Wu X, Yang H, Li X Mol Biotechnol. 2023; 66(9):2332-2340.

PMID: 37682457 DOI: 10.1007/s12033-023-00844-6.

References

Cao Z, Pan X, Yang Y, Huang Y, Shen H . The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics. 2018; 34(13):2185-2194. DOI: 10.1093/bioinformatics/bty085. View

Lin Y, Pan X, Shen H . lncLocator 2.0: a cell-line-specific subcellular localization predictor for long non-coding RNAs with interpretable deep learning. Bioinformatics. 2021; 37(16):2308-2316. DOI: 10.1093/bioinformatics/btab127. View

Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z . Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell. 2019; 179(2):561-577.e22. DOI: 10.1016/j.cell.2019.08.052. View

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

Klingenberg M, Becker J, Eberth S, Kube D, Wilting J . The chick chorioallantoic membrane as an in vivo xenograft model for Burkitt lymphoma. BMC Cancer. 2014; 14:339. PMC: 4036709. DOI: 10.1186/1471-2407-14-339. View

Chen L . Linking Long Noncoding RNA Localization and Function. Trends Biochem Sci. 2016; 41(9):761-772. DOI: 10.1016/j.tibs.2016.07.003. View

Wang S, Xu M, Sun Z, Yu X, Deng Y, Chang H . LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p. Am J Physiol Gastrointest Liver Physiol. 2019; 317(2):G116-G126. DOI: 10.1152/ajpgi.00005.2019. View

Umer M, Qureshi S, Hashmi Z, Raza A, Ahmad J, Rahman M . Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis. Virol J. 2014; 11:117. PMC: 4076499. DOI: 10.1186/1743-422X-11-117. View

Lim L, Wong S, Huang F, Lim S, Chong S, Ooi L . Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Res. 2019; 79(20):5131-5139. DOI: 10.1158/0008-5472.CAN-19-0255. View

10.

Pinto M, Ribeiro A, Conde I, Carvalho R, Paredes J . The Chick Chorioallantoic Membrane Model: A New In Vivo Tool to Evaluate Breast Cancer Stem Cell Activity. Int J Mol Sci. 2021; 22(1). PMC: 7795925. DOI: 10.3390/ijms22010334. View

11.

Wang H, Huo X, Yang X, He J, Cheng L, Wang N . STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017; 16(1):136. PMC: 5558651. DOI: 10.1186/s12943-017-0680-1. View

12.

Mikhail S, Cosgrove D, Zeidan A . Hepatocellular carcinoma: systemic therapies and future perspectives. Expert Rev Anticancer Ther. 2014; 14(10):1205-18. DOI: 10.1586/14737140.2014.949246. View

13.

Xie Y . Hepatitis B Virus-Associated Hepatocellular Carcinoma. Adv Exp Med Biol. 2017; 1018:11-21. DOI: 10.1007/978-981-10-5765-6_2. View

14.

Zhang H, Yu C, Chen M, Li Z, Tian S, Jiang J . miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2. Tumour Biol. 2016; 37(8):11321-9. DOI: 10.1007/s13277-016-4995-0. View

15.

Fatica A, Bozzoni I . Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2013; 15(1):7-21. DOI: 10.1038/nrg3606. View

16.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

17.

Zheng Y, Li L, Jia Y, Zhang B, Li J, Zhu Y . LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway. Theranostics. 2019; 9(3):796-810. PMC: 6376468. DOI: 10.7150/thno.28992. View

18.

Shi Y, Qi B, Liu X, Ding H . Upregulation of miR-522 is associated with poor outcome of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2016; 20(15):3194-8. View

19.

Avram S, Coricovac D, Pavel I, Pinzaru I, Ghiulai R, Baderca F . Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice. Oncol Rep. 2017; 38(1):89-99. PMC: 5492638. DOI: 10.3892/or.2017.5658. View

20.

Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C . Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer. 2017; 16(1):123. PMC: 5514467. DOI: 10.1186/s12943-017-0702-z. View